Syneos Health Executive VP and Data Expert Discusses RWE and Aetion Collaboration

Executive Vice President of Real World Evidence (RWE) and Late Phase at Syneos Health Javier Jimenez discusses major industry trends and his organization’s recent partnership with Aetion. RWE can be used throughout the drug development pipeline to improve patient outcomes.

“We can empower market access and medical affairs teams to communicate findings to stakeholders, and work with commercial teams to understand how their resources are allocated, identify areas of unmet medical need where their product could make a bigger impact, and gather the evidence medical science liaisons need to communicate to physicians.” Read more here.

(Source: Aetion, 9/30/21)